Literature DB >> 23774526

Mutational landscape of basal cell carcinomas by whole-exome sequencing.

Shyam S Jayaraman1, David J Rayhan2, Salar Hazany2, Michael S Kolodney3.   

Abstract

Recent advances in sequencing technology allow genome-scale approaches to cancer mutation discovery. Such data-intensive methods have been applied to cutaneous squamous cell carcinomas (SCCs) and melanomas but have not, to our knowledge, been applied to basal cell carcinomas (BCCs). We used whole-exome sequencing to characterize the mutational landscape of sporadic BCCs. We show that BCCs are the most mutated type of human cancer. Tumors from anatomical regions with chronic UV exposure were associated with higher mutation rates than those with intermittent exposure. The majority of all mutations (75.7%) were UV signature. Using a conventional binomial probability model, several genes were found mutated significantly. However, this model assumes a uniform distribution of mutations throughout the genome. We also used a more stringent approach called InVEx that uses a permutation-based framework to pick drivers from passengers. After correction for multiple hypothesis testing, InVEx identified only PTCH1 (Patched 1) as having a significant functional mutation burden. We also found three genes, STAT5B, CRNKL1, and NEBL, with mutational hot spots at a single base in 3 of 12 tumors sequenced. Our findings support the central role of PTCH1 mutations in BCC genesis. Moreover, our discovery of the uniquely high number of mutations in this tumor may lend insight into its biological behavior.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23774526     DOI: 10.1038/jid.2013.276

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  36 in total

1.  Human homolog of patched, a candidate gene for the basal cell nevus syndrome.

Authors:  R L Johnson; A L Rothman; J Xie; L V Goodrich; J W Bare; J M Bonifas; A G Quinn; R M Myers; D R Cox; E H Epstein; M P Scott
Journal:  Science       Date:  1996-06-14       Impact factor: 47.728

2.  The Catalogue of Somatic Mutations in Cancer (COSMIC).

Authors:  S A Forbes; G Bhamra; S Bamford; E Dawson; C Kok; J Clements; A Menzies; J W Teague; P A Futreal; M R Stratton
Journal:  Curr Protoc Hum Genet       Date:  2008-04

3.  The STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions.

Authors:  Thomas G P Grunewald; Horacio Bach; Andrea Cossarizza; Isao Matsumoto
Journal:  Biol Cell       Date:  2012-09-24       Impact factor: 4.458

4.  Overexpression of p53 protein in basal cell carcinomas of human skin.

Authors:  C R Shea; N S McNutt; M Volkenandt; J Lugo; P G Prioleau; A P Albino
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

5.  UV-radiation-specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma.

Authors:  A Ouhtit; H Nakazawa; B K Armstrong; A Kricker; E Tan; H Yamasaki; D R English
Journal:  J Natl Cancer Inst       Date:  1998-04-01       Impact factor: 13.506

Review 6.  Metastatic basal cell carcinoma in the era of hedgehog signaling pathway inhibitors.

Authors:  Glen J Weiss; Ronald L Korn
Journal:  Cancer       Date:  2012-04-17       Impact factor: 6.860

7.  Vismodegib.

Authors:  Charles M Rudin
Journal:  Clin Cancer Res       Date:  2012-06-07       Impact factor: 12.531

8.  Location of gene for Gorlin syndrome.

Authors:  P A Farndon; R G Del Mastro; D G Evans; M W Kilpatrick
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

9.  Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome.

Authors:  H Hahn; C Wicking; P G Zaphiropoulous; M R Gailani; S Shanley; A Chidambaram; I Vorechovsky; E Holmberg; A B Unden; S Gillies; K Negus; I Smyth; C Pressman; D J Leffell; B Gerrard; A M Goldstein; M Dean; R Toftgard; G Chenevix-Trench; B Wainwright; A E Bale
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

10.  Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.

Authors:  Nicholas J Wang; Zachary Sanborn; Kelly L Arnett; Laura J Bayston; Wilson Liao; Charlotte M Proby; Irene M Leigh; Eric A Collisson; Patricia B Gordon; Lakshmi Jakkula; Sally Pennypacker; Yong Zou; Mimansa Sharma; Jeffrey P North; Swapna S Vemula; Theodora M Mauro; Isaac M Neuhaus; Philip E Leboit; Joe S Hur; Kyunghee Park; Nam Huh; Pui-Yan Kwok; Sarah T Arron; Pierre P Massion; Allen E Bale; David Haussler; James E Cleaver; Joe W Gray; Paul T Spellman; Andrew P South; Jon C Aster; Stephen C Blacklow; Raymond J Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

View more
  69 in total

Review 1.  Advanced basal cell cancer: concise review of molecular characteristics and novel targeted and immune therapeutics.

Authors:  M Nikanjam; P R Cohen; S Kato; J K Sicklick; R Kurzrock
Journal:  Ann Oncol       Date:  2018-11-01       Impact factor: 32.976

Review 2.  [Molecular genetic investigations as the basis for targeted treatment of basal cell carcinoma of the eye].

Authors:  L Boeckmann; M C Martens; V Kakkassery; L M Heindl; S Emmert
Journal:  Ophthalmologe       Date:  2020-02       Impact factor: 1.059

3.  Error-Prone Replication through UV Lesions by DNA Polymerase θ Protects against Skin Cancers.

Authors:  Jung-Hoon Yoon; Mark J McArthur; Jeseong Park; Debashree Basu; Maki Wakamiya; Louise Prakash; Satya Prakash
Journal:  Cell       Date:  2019-02-14       Impact factor: 41.582

4.  Metastatic Basal Cell Carcinoma.

Authors:  Alvaro C Laga; Inga Marie Schaefer; Lynette M Sholl; Christopher A French; John Hanna
Journal:  Am J Clin Pathol       Date:  2019-11-04       Impact factor: 2.493

Review 5.  Skin cancer and vitamin D: an update.

Authors:  Candy Wyatt; Rachel E Neale; Robyn M Lucas
Journal:  Melanoma Manag       Date:  2015-02-25

6.  Response to Emanuele.

Authors:  Quentin Gueranger; Feng Li; Matthew Peacock; Annabel Larnicol-Fery; Reto Brem; Peter Macpherson; Jean-Marc Egly; Peter Karran
Journal:  J Invest Dermatol       Date:  2014-02-03       Impact factor: 8.551

7.  Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma.

Authors:  Hayley J Sharpe; Gregoire Pau; Gerrit J Dijkgraaf; Nicole Basset-Seguin; Zora Modrusan; Thomas Januario; Vickie Tsui; Alison B Durham; Andrzej A Dlugosz; Peter M Haverty; Richard Bourgon; Jean Y Tang; Kavita Y Sarin; Luc Dirix; David C Fisher; Charles M Rudin; Howard Sofen; Michael R Migden; Robert L Yauch; Frederic J de Sauvage
Journal:  Cancer Cell       Date:  2015-03-09       Impact factor: 31.743

8.  Smoothened variants explain the majority of drug resistance in basal cell carcinoma.

Authors:  Scott X Atwood; Kavita Y Sarin; Ramon J Whitson; Jiang R Li; Geurim Kim; Melika Rezaee; Mina S Ally; Jinah Kim; Catherine Yao; Anne Lynn S Chang; Anthony E Oro; Jean Y Tang
Journal:  Cancer Cell       Date:  2015-03-09       Impact factor: 31.743

9.  Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma.

Authors:  Markus Eberl; Doris Mangelberger; Jacob B Swanson; Monique E Verhaegen; Paul W Harms; Marcus L Frohm; Andrzej A Dlugosz; Sunny Y Wong
Journal:  Cancer Cell       Date:  2018-01-27       Impact factor: 31.743

10.  Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.

Authors:  Ximena Bonilla; Laurent Parmentier; Bryan King; Fedor Bezrukov; Gürkan Kaya; Vincent Zoete; Vladimir B Seplyarskiy; Hayley J Sharpe; Thomas McKee; Audrey Letourneau; Pascale G Ribaux; Konstantin Popadin; Nicole Basset-Seguin; Rouaa Ben Chaabene; Federico A Santoni; Maria A Andrianova; Michel Guipponi; Marco Garieri; Carole Verdan; Kerstin Grosdemange; Olga Sumara; Martin Eilers; Iannis Aifantis; Olivier Michielin; Frederic J de Sauvage; Stylianos E Antonarakis; Sergey I Nikolaev
Journal:  Nat Genet       Date:  2016-03-07       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.